AI Product

Segmed — Healthcare Analytics

Real-World Imaging Data (RWiD) platform and Openda insight tools providing de-identified, regulatory-grade medical imaging datasets with reports and multimodal data…

Intelligence Summary

Product
  • Active
  • Verified public sources
  • Developer Segmed
  • Category Healthcare Analytics
  • Status Active
  • Latest update 2019: Segmed co-founded by Stanford engineers and physicians including Jie Wu and Martin Willemink.
  • Documentation Official page
  • Last reviewed Jul 2026
6 Technologies

Official product page

Target customer

Medical AI developers, pharmaceutical R&D teams, medical device manufacturers, and academic researchers needing diverse imaging data for training, validation, and real-world evidence studies.

Features & capabilities

Industries: AI in Healthcare; Healthcare Analytics

Related reports

Related insights

Overview

Real-World Imaging Data (RWiD) platform and Openda insight tools providing de-identified, regulatory-grade medical imaging datasets with reports and multimodal data for AI development, clinical research, and FDA submission support.

Product and company

Segmed — Healthcare Analytics is a verified product offering linked to the Brel Digital company profile for Segmed.

Use cases

Real-World Imaging Data (RWiD) platform and Openda insight tools providing de-identified, regulatory-grade medical imaging datasets with reports and multimodal data for AI development, clinical research, and FDA submission support.

Target customer

Medical AI developers, pharmaceutical R&D teams, medical device manufacturers, and academic researchers needing diverse imaging data for training, validation, and real-world evidence studies.

Technologies

Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Large Language Models, Machine Learning, Medical Imaging, Predictive Analytics.

Sources and references

  • Official product / company source: https://www.segmed.ai/news/imerit-segmed-advocate-announce-3d-mammography-dataset-ai-research-in-breast-cancer-detection
  • Supporting source: https://www.segmed.ai/team-members/martin-willemink

Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.

Last reviewed

This product profile was last reviewed on 2026-07-14.

Correction request

If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.

Features and capabilities

  • Real-World Imaging Data (RWiD) platform and Openda insight tools providing de-identified, regulatory-grade medical imaging datasets with reports and multimodal data for AI development, clinical research, and FDA submission support.

Extracted from the linked company product description already verified on Brel. No capabilities were invented.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

Enquire about this product profile

Messages are delivered to contact@breldigital.com.